C

Casma Therapeutics

34 employees

Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2018

Funding rounds raised

Total raised

$50M

from 10 investors over 10 rounds

C

Casma Therapeutics raised $46M on November 15, 2022

Investors: Eventide Management Partners, Schroders Capital, Astellas Venture Capital L.L.C., The Column Group, Eisai Asia, Mirae Asset MAPS Global Investments Co., Ltd and Third Rock Ventures

C

Casma Therapeutics raised $50M on September 10, 2020

Investors: Eventide Asset Management, Third Rock Ventures and The Column Group

FAQ